Advertisement.

RYTM Projected Dividend Yield

Rhythm Pharmaceuticals Inc ( NASDAQ : RYTM )

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company to transform the lives of patients and their families living with rare diseases. Co. is focused on developing IMCIVREE® (setmelanotide), as a medicine designed to treat hyperphagia and severe obesity caused by melanocortin-4 receptor pathway diseases. IMCIVREE is approved by the U.S. Food and Drug Administration for chronic weight management in adult and pediatric patients six years of age and older with monogenic or syndromic obesity due to: proopiomelanocortin, proprotein convertase subtilisin/kexin type 1 or leptin receptor deficiency; or Bardet-Biedl syndrome.

20 YEAR PERFORMANCE RESULTS

RYTM Dividend History Detail
RYTM Dividend News
RYTM Competitors News

# of Shares: 0

Closing Price: 55.24

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000